Anna-Karin E. Palm

2.2k total citations
17 papers, 840 citations indexed

About

Anna-Karin E. Palm is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Anna-Karin E. Palm has authored 17 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 4 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Anna-Karin E. Palm's work include T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (6 papers). Anna-Karin E. Palm is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (6 papers). Anna-Karin E. Palm collaborates with scholars based in Sweden and United States. Anna-Karin E. Palm's co-authors include Carole Henry, Patrick C. Wilson, Florian Krammer, Sandra Kleinau, Karlynn E. Neu, Min Huang, Linda Yu-Ling Lan, Brandon J. DeKosky, George Georgiou and Sarah F. Andrews and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Scientific Reports.

In The Last Decade

Anna-Karin E. Palm

16 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna-Karin E. Palm Sweden 12 473 289 253 152 75 17 840
Mattias N.E. Forsell Sweden 21 661 1.4× 187 0.6× 387 1.5× 212 1.4× 127 1.7× 54 1.2k
Lauren B. Rodda United States 9 707 1.5× 259 0.9× 181 0.7× 275 1.8× 31 0.4× 13 1.2k
Mary K. Wloch United States 14 336 0.7× 497 1.7× 226 0.9× 185 1.2× 79 1.1× 22 856
Xiaocong Yu United States 9 311 0.7× 265 0.9× 174 0.7× 185 1.2× 135 1.8× 23 740
Mark D. Hicar United States 13 281 0.6× 224 0.8× 203 0.8× 195 1.3× 119 1.6× 37 761
Lars Frelin Sweden 20 378 0.8× 675 2.3× 210 0.8× 245 1.6× 93 1.2× 49 1.2k
Doan C. Nguyen United States 18 335 0.7× 618 2.1× 412 1.6× 207 1.4× 92 1.2× 29 1.1k
Kaval Kaur United States 10 454 1.0× 536 1.9× 235 0.9× 197 1.3× 166 2.2× 12 862
Ricardo da Silva Antunes United States 15 502 1.1× 259 0.9× 680 2.7× 295 1.9× 25 0.3× 42 1.3k
Juliana Bessa Switzerland 13 664 1.4× 225 0.8× 134 0.5× 311 2.0× 199 2.7× 18 1.0k

Countries citing papers authored by Anna-Karin E. Palm

Since Specialization
Citations

This map shows the geographic impact of Anna-Karin E. Palm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Karin E. Palm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Karin E. Palm more than expected).

Fields of papers citing papers by Anna-Karin E. Palm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna-Karin E. Palm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Karin E. Palm. The network helps show where Anna-Karin E. Palm may publish in the future.

Co-authorship network of co-authors of Anna-Karin E. Palm

This figure shows the co-authorship network connecting the top 25 collaborators of Anna-Karin E. Palm. A scholar is included among the top collaborators of Anna-Karin E. Palm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna-Karin E. Palm. Anna-Karin E. Palm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Carow, Berit, Jens Eriksson, Karin Lövgren Bengtsson, et al.. (2025). Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization. npj Vaccines. 10(1). 184–184.
3.
Vieira, Marcos C., Anna-Karin E. Palm, Christopher T. Stamper, et al.. (2023). Germline-encoded specificities and the predictability of the B cell response. PLoS Pathogens. 19(8). e1011603–e1011603. 3 indexed citations
4.
Stertman, Linda, Anna-Karin E. Palm, Berit Carow, et al.. (2023). The Matrix-M™ adjuvant: A critical component of vaccines for the 21 st century. Human Vaccines & Immunotherapeutics. 19(1). 2189885–2189885. 59 indexed citations
5.
Carnrot, Cecilia, Berit Carow, Anna-Karin E. Palm, et al.. (2023). Biodistribution of the saponin-based adjuvant Matrix-M™ following intramuscular injection in mice. SHILAP Revista de lepidopterología. 3. 1279710–1279710. 6 indexed citations
6.
Palm, Anna-Karin E. & Sandra Kleinau. (2021). Marginal zone B cells: From housekeeping function to autoimmunity?. Journal of Autoimmunity. 119. 102627–102627. 60 indexed citations
7.
Dugan, Haley L., Jenna J. Guthmiller, Philip Arevalo, et al.. (2020). Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans. Science Translational Medicine. 12(573). 72 indexed citations
8.
Henry, Carole, Anna-Karin E. Palm, Henry A. Utset, et al.. (2019). Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study. Journal of Virology. 93(21). 18 indexed citations
9.
Palm, Anna-Karin E. & Carole Henry. (2019). Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination. Frontiers in Immunology. 10. 1787–1787. 180 indexed citations
10.
Henry, Carole, Anna-Karin E. Palm, Florian Krammer, & Patrick C. Wilson. (2017). From Original Antigenic Sin to the Universal Influenza Virus Vaccine. Trends in Immunology. 39(1). 70–79. 179 indexed citations
11.
Lan, Linda Yu-Ling, Sarah F. Andrews, Carole Henry, et al.. (2017). Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation. Science Immunology. 2(7). 162 indexed citations
12.
Palm, Anna-Karin E., et al.. (2016). Nodal marginal zone B cells in mice: a novel subset with dormant self-reactivity. Scientific Reports. 6(1). 27687–27687. 20 indexed citations
13.
Palm, Anna-Karin E., et al.. (2016). Activated mast cells promote differentiation of B cells into effector cells. Scientific Reports. 6(1). 20531–20531. 22 indexed citations
14.
Palm, Anna-Karin E., Ove Wattle, Torbjörn Lundström, & Eva Wattrang. (2016). Secretory immunoglobulin A and immunoglobulin G in horse saliva. Veterinary Immunology and Immunopathology. 180. 59–65. 7 indexed citations
15.
Palm, Anna-Karin E., et al.. (2015). Function and regulation of self-reactive marginal zone B cells in autoimmune arthritis. Cellular and Molecular Immunology. 12(4). 493–504. 21 indexed citations
16.
Wattrang, Eva, Anna-Karin E. Palm, & Bettina Wagner. (2012). Cytokine production and proliferation upon in vitro oligodeoxyribonucleotide stimulation of equine peripheral blood mononuclear cells. Veterinary Immunology and Immunopathology. 146(2). 113–124. 14 indexed citations
17.
Su, Jianguo, Peter Horal, Mojgan H. Naghavi, et al.. (2001). The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.. PubMed. 4(1). 1–7. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026